Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Coronary Disease: full-pipeline trial registry
1 of 36 indexed Coronary Disease trials are currently recruiting.
Corpus placement: #419 of 28,707 conditions by registered trial count.
36 US clinical trials · 1 currently recruiting · #419 of 28,707 conditions by registered trial count
Coronary Disease: 36 US clinical trials tracked, 1 recruiting.
Coronary Disease is the subject of 36 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is National Heart, Lung, and Blood Institute (NHLBI), running 10 of these trials.
Enrollment posture brief
Registry condition coronary-disease
OPEN 1 | RECR 3% | LATE 5 | EARLY 6 | RANK #419 | SPON 10
Volume-matched condition peers
Nearest open-share peer: Acne Vulgaris (3% recruiting · 68 trials)
Coronary Disease lists 1 open slots (3% of 36 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Coronary Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Coronary Disease is recruiting below its size-band peers.
1 of 36 indexed trials (2.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Coronary Disease research.
National Heart, Lung, and Blood Institute (NHLBI) accounts for 10 of 36 trials (27.8%). 23 distinct sponsors appear on at least one study for this condition label.
-
Typical Coronary Disease enrolment sits around 360 participants.
Median target enrolment is 360 among the 35 trials that report a genuine target (sentinel values excluded). 6 of those (17.1%) plan for fewer than 100 participants.
-
Coronary Disease splits between interventional and observational designs.
20 interventional and 16 observational studies make up this index (55.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
36 total, page 1 of 1
Evaluating New Radiation Techniques for Cardiovascular Imaging
National Heart, Lung, and Blood Institute (NHLBI)
NCT01621594
Bogalusa Heart Study
Tulane University
NCT00005129
University of North Carolina Alumni Heart Study
Duke University
NCT00005398
Cardiovascular Health Study (CHS)
National Heart, Lung, and Blood Institute (NHLBI)
NCT00005133
The Jackson Heart Study of Cardiovascular Disease Among African Americans
National Heart, Lung, and Blood Institute (NHLBI)
NCT00005485
Mediators of Atherosclerosis in South Asians Living in America
University of California, San Francisco
NCT01207167
Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy
Johns Hopkins University
NCT02694094
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
National Heart, Lung, and Blood Institute (NHLBI)
NCT00000620
International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
NYU Langone Health
NCT01471522
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)
Abbott Medical Devices
NCT01120379
Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease
Duke University
NCT00023595
A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
Stanford University
NCT02100722
Examining How Heart Disease Risk Factors Affect Healthy Aging (The Chicago Healthy Aging Study [CHAS])
Northwestern University
NCT00626379
A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease
Pfizer
NCT00134173
IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.
Tufts Medical Center
NCT00091507
Heart Rate Variability and Sudden Cardiac Death
Columbia University
NCT00005235
Comparison of Two Methods to Diagnose Coronary Artery Disease
Johns Hopkins University
NCT00063531
Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery
Duke University
NCT00041392
MRI Evaluation of Chest Pain
National Heart, Lung, and Blood Institute (NHLBI)
NCT00001961
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
University of Washington
NCT00880178
Estrogen, HDL, and Coronary Heart Disease in Women
Tufts University
NCT00083824
Collaborative Cardiac Care Project
US Department of Veterans Affairs
NCT00105664
Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation
Baylor Research Institute
NCT00224809
Detection of Coronary Artery Calcification: Comparison of Volumetric and Electron Beam Computed Tomography
National Institutes of Health Clinical Center (CC)
NCT00001836
Study of the Interaction Between the Cells Lining Blood Vessels and Angiotensin-Converting Enzyme
National Heart, Lung, and Blood Institute (NHLBI)
NCT00001461
Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle
National Heart, Lung, and Blood Institute (NHLBI)
NCT00001891
Sapphire 3 CTO Study
OrbusNeich
NCT06358508
Atherosclerosis in the Coronary and Carotid Arteries
National Heart, Lung, and Blood Institute (NHLBI)
NCT00080587
Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent
Marc Sakwa, MD
NCT01681095
Cardiac Computed Tomography In the Management of Patients With indeterminAte or inConclusive Stress Tests
Corewell Health East
NCT00541203
Time Restricted Feeding for Weight Loss and Cardio-protection
University of Illinois at Chicago
NCT02948517
Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation
National Heart, Lung, and Blood Institute (NHLBI)
NCT00005928
Nitric Oxide Inhalation Therapy to Relieve Chest Pain in Patients With Coronary Artery Disease
National Heart, Lung, and Blood Institute (NHLBI)
NCT00014040
Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions
Abbott Medical Devices
NCT02229864
Platelet Activation Markers in Pediatric Cardiac Surgery
Weill Medical College of Cornell University
NCT00450151
Effects of Training Intensity on the CHD Risk Factors in Postmenopausal Women
National Center for Research Resources (NCRR)
NCT00000108
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 6 |
| Phase 3 | 5 |
Top Sponsors
Named interventions
Most-linked intervention names on Coronary Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Coronary Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Coronary Disease page
36 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Coronary Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Heart, Lung, and Blood Institute (NHLBI) sponsors the most Coronary Disease trials on record, review their full trial history before evaluating a specific study. See National Heart, Lung, and Blood Institute (NHLBI)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Coronary Disease condition card totals 36 registered trials; most-linked intervention Placebo; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.